Pancreatic Cancer Research

ResearcherThe University of OsakaActive in the last 2 years

Tomoki Sugimoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5073486682. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 2 papers

Papers 2

  1. Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15118-x↗
  2. ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15349-y↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tadafumi Asaoka · 2 shared papers, 2024 · strength 0.38
  2. Yuichiro Doki · 2 shared papers, 2024 · strength 0.38
  3. Yoshifumi Iwagami · 2 shared papers, 2024 · strength 0.38
  4. Hidetoshi Eguchi · 2 shared papers, 2024 · strength 0.38
  5. Yoshito Tomimaru · 2 shared papers, 2024 · strength 0.38
  6. Daisaku Yamada · 2 shared papers, 2024 · strength 0.38
  7. Hidenori Takahashi · 2 shared papers, 2024 · strength 0.38
  8. Kazuki Sasaki · 2 shared papers, 2024 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.